$84.08
0.700.85%
Last update: Dec 16, 10:13 AM
Comments
Loading...
Edwards Lifesciences Stock Guidance | NYSE:EW | Benzinga
Edwards Lifesciences issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 12/04/2025 | EW | Edwards Lifesciences | FY | 2026 | $2.80 | $2.95 | $2.86 | $6.40B | $6.80B | $6.61B | Get Alert |
| 12/04/2025 | EW | Edwards Lifesciences | FY | 2025 | $2.56 | $2.62 | $2.59 | $5.98B | $5.98B | $6.03B | Get Alert |
| 10/30/2025 | EW | Edwards Lifesciences | FY | 2025 | $2.56 | $2.62 | $2.51 | $5.93B | $6.10B | $5.98B | Get Alert |
| 10/30/2025 | EW | Edwards Lifesciences | Q4 | 2025 | $0.58 | $0.64 | $0.59 | $1.51B | $1.59B | $1.50B | Get Alert |
| 08/06/2025 | EW | Edwards Lifesciences | FY | 2025 | $2.45 | $2.55 | $2.49 | — | — | — | Get Alert |
| 07/24/2025 | EW | Edwards Lifesciences | Q3 | 2025 | $0.54 | $0.60 | $0.62 | $1.46B | $1.54B | $1.49B | Get Alert |
| 07/24/2025 | EW | Edwards Lifesciences | FY | 2025 | $2.40 | $2.50 | $2.47 | $5.90B | $6.10B | $5.90B | Get Alert |
| 04/23/2025 | EW | Edwards Lifesciences | FY | 2025 | $2.40 | $2.50 | $2.45 | $5.70B | $6.10B | $5.82B | Get Alert |
| 04/23/2025 | EW | Edwards Lifesciences | Q2 | 2025 | $0.59 | $0.65 | $0.62 | $1.45B | $1.53B | $1.46B | Get Alert |
| 02/11/2025 | EW | Edwards Lifesciences | FY | 2025 | $2.40 | $2.50 | $2.45 | $5.60B | $6.00B | $5.84B | Get Alert |
| 02/11/2025 | EW | Edwards Lifesciences | Q1 | 2025 | $0.58 | $0.64 | $0.59 | $1.35B | $1.43B | $1.42B | Get Alert |
| 12/04/2024 | EW | Edwards Lifesciences | FY | 2024 | — | — | — | $6.49B | $6.61B | $5.83B | Get Alert |
| 12/04/2024 | EW | Edwards Lifesciences | FY | 2025 | $2.40 | $2.50 | $2.47 | $5.60B | $6.00B | $5.92B | Get Alert |
| 10/24/2024 | EW | Edwards Lifesciences | FY | 2024 | — | — | — | $6.49B | $6.61B | $6.13B | Get Alert |
| 10/24/2024 | EW | Edwards Lifesciences | Q4 | 2024 | $0.53 | $0.57 | $0.62 | $1.33B | $1.39B | $1.44B | Get Alert |
| 07/24/2024 | EW | Edwards Lifesciences | Q3 | 2024 | $0.67 | $0.71 | $0.69 | $1.56B | $1.64B | $1.62B | Get Alert |
| 04/25/2024 | EW | Edwards Lifesciences | FY | 2024 | $2.70 | $2.80 | $2.75 | $6.60B | $6.60B | $6.52B | Get Alert |
| 04/25/2024 | EW | Edwards Lifesciences | Q2 | 2024 | $0.67 | $0.71 | $0.70 | $1.62B | $1.70B | $1.64B | Get Alert |
| 02/06/2024 | EW | Edwards Lifesciences | FY | 2024 | $2.70 | $2.80 | $2.76 | $6.30B | $6.60B | $6.48B | Get Alert |
| 02/06/2024 | EW | Edwards Lifesciences | Q1 | 2024 | $0.62 | $0.66 | $0.66 | $1.53B | $1.61B | $1.56B | Get Alert |
| 12/07/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.47 | $2.53 | $2.51 | $5.90B | $6.10B | $5.97B | Get Alert |
| 12/07/2023 | EW | Edwards Lifesciences | FY | 2024 | $2.70 | $2.80 | $2.80 | $6.30B | $6.60B | $6.51B | Get Alert |
| 10/25/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.50 | $2.60 | $2.55 | $5.92B | $6.08B | $6.00B | Get Alert |
| 10/25/2023 | EW | Edwards Lifesciences | Q4 | 2023 | $0.60 | $0.66 | $0.68 | $1.45B | $1.53B | $1.54B | Get Alert |
| 07/26/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.50 | $2.60 | $2.55 | $5.90B | $6.10B | $5.96B | Get Alert |
| 07/26/2023 | EW | Edwards Lifesciences | Q3 | 2023 | $0.55 | $0.61 | $0.63 | $1.44B | $1.52B | $1.47B | Get Alert |
| 04/26/2023 | EW | Edwards Lifesciences | Q2 | 2023 | $0.62 | $0.68 | $0.63 | $1.48B | $1.56B | $1.46B | Get Alert |
| 04/26/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.48 | $2.60 | $2.52 | $6.00B | $6.00B | $5.85B | Get Alert |
| 01/31/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.45 | $2.60 | $2.50 | $5.60B | $6.00B | $5.78B | Get Alert |
| 01/31/2023 | EW | Edwards Lifesciences | Q1 | 2023 | $0.58 | $0.64 | $0.59 | $1.37B | $1.45B | $1.37B | Get Alert |
| 12/08/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.40 | $2.50 | $2.45 | $5.35B | $5.35B | $5.36B | Get Alert |
| 12/08/2022 | EW | Edwards Lifesciences | FY | 2023 | $2.45 | $2.60 | $2.52 | $5.60B | $6.00B | $5.71B | Get Alert |
| 10/27/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.40 | $2.50 | $2.51 | $5.35B | $5.35B | $5.47B | Get Alert |
| 07/28/2022 | EW | Edwards Lifesciences | Q3 | 2022 | $0.58 | $0.66 | $0.65 | $1.30B | $1.37B | $1.44B | Get Alert |
| 07/28/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.50 | $2.50 | $2.56 | $5.35B | $5.55B | $5.71B | Get Alert |
| 04/26/2022 | EW | Edwards Lifesciences | Q2 | 2022 | $0.61 | $0.69 | $0.65 | $1.36B | $1.44B | $1.46B | Get Alert |
| 04/26/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.50 | $2.65 | $2.55 | $5.50B | $6.00B | $5.76B | Get Alert |
| 01/26/2022 | EW | Edwards Lifesciences | Q1 | 2022 | $0.54 | $0.62 | $0.60 | $1.27B | $1.35B | $1.36B | Get Alert |
| 01/26/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.50 | $2.65 | $2.58 | $5.50B | $6.00B | $5.82B | Get Alert |
FAQ
Q
What is the most recent guidance for Edwards Lifesciences (EW)?
A
The most recent guidance for Edwards Lifesciences (EW) was reported on December 4, 2025 for the full year 2026. The company provided earnings per share guidance in the range of $2.80 to $2.95, compared to the estimated EPS of $2.86. Additionally, Edwards Lifesciences forecasted revenue between $6.40B and $6.80B for the quarter.
Browse guidance and forecast on all stocks.
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved